New report reveals consequences of Trump administration's HIV/AIDS funding cuts

Key Points:

• The 26th International AIDS Conference in Rio highlights concerns over significant funding cuts to the U.S. PEPFAR program, which has saved over 26 million lives since 2003, leading to closures of more than 1,700 treatment sites worldwide.
• A report by amfAR reveals that 73% of organizations serving vulnerable groups and 63% of those preventing mother-to-child HIV transmission have faced service disruptions, risking a resurgence of HIV infections and increased transmission to newborns.
• Dr. Atul Gawande emphasizes that political decisions, not scientific limitations, are hindering progress against HIV/AIDS, noting the U.S. has reduced partnerships with high-burden countries like South Africa and cut funding for vaccine development despite advances like the new injectable prevention drug lenacapavir.
• The U.S. State Department disputes the severity of the crisis, claiming continued distribution of treatments through alternative channels, but experts argue reduced funding limits reach and specialized services, especially for marginalized populations.
• In addition to HIV/AIDS, the ongoing Ebola outbreak in the Democratic Republic of Congo is worsening, with over 3,200 cases and insufficient response capacity due to prior reductions in infrastructure and expertise, making it one of the largest Ebola outbreaks in history.